CATALOGO DEI PRODOTTI DELLA RICERCA

PIZZOLO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.902
NA - Nord America 8.568
AS - Asia 5.140
SA - Sud America 693
AF - Africa 78
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 23.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.447
RU - Federazione Russa 3.406
SG - Singapore 2.115
GB - Regno Unito 1.960
CN - Cina 1.664
DE - Germania 889
BR - Brasile 580
SE - Svezia 576
FI - Finlandia 446
FR - Francia 439
IT - Italia 432
HK - Hong Kong 430
IE - Irlanda 387
VN - Vietnam 363
KR - Corea 169
UA - Ucraina 109
CA - Canada 75
JP - Giappone 74
TR - Turchia 70
BE - Belgio 59
IN - India 51
AR - Argentina 46
NL - Olanda 46
PL - Polonia 40
ZA - Sudafrica 34
BD - Bangladesh 33
ID - Indonesia 32
MX - Messico 29
ES - Italia 26
AT - Austria 22
IR - Iran 17
CO - Colombia 15
IL - Israele 14
AZ - Azerbaigian 12
CL - Cile 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
VE - Venezuela 11
EC - Ecuador 10
EG - Egitto 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
PK - Pakistan 9
SA - Arabia Saudita 8
LT - Lituania 7
PY - Paraguay 7
EU - Europa 6
JO - Giordania 6
MA - Marocco 6
DZ - Algeria 5
HR - Croazia 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
RO - Romania 4
AL - Albania 3
BJ - Benin 3
BN - Brunei Darussalam 3
DK - Danimarca 3
EE - Estonia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TG - Togo 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
HN - Honduras 2
HU - Ungheria 2
ME - Montenegro 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
Totale 23.383
Salva come PNG Salva come JPEG
Città #
Southend 1.627
Moscow 1.162
Singapore 1.087
Chandler 1.050
Jacksonville 1.029
Dallas 988
Ashburn 683
Woodbridge 658
Ann Arbor 549
Hong Kong 423
Dublin 385
Houston 295
New York 274
Beijing 251
The Dalles 173
Verona 171
Wilmington 170
Lawrence 156
Princeton 156
Los Angeles 146
Munich 138
Jinan 122
Helsinki 118
Nanjing 116
Boardman 109
Ho Chi Minh City 103
Shenyang 77
Hanoi 73
Tokyo 73
Lancaster 72
Tianjin 71
Turku 67
Buffalo 66
São Paulo 62
Hebei 60
Nürnberg 60
Brussels 59
Columbus 57
Redondo Beach 57
Sindelfingen 56
Dong Ket 54
Santa Clara 53
Milan 50
Zhengzhou 49
Nanchang 43
Seoul 43
Changsha 39
Redmond 38
Guangzhou 36
Denver 35
Haikou 35
Hangzhou 33
Seattle 33
Ningbo 32
Warsaw 32
London 30
Jiaxing 29
Montreal 29
Stockholm 29
Washington 29
Toronto 27
Taiyuan 25
Boston 24
Taizhou 24
Phoenix 23
Falkenstein 22
Johannesburg 22
Poplar 22
Chicago 21
Chennai 19
Padova 19
Rio de Janeiro 19
Brooklyn 18
San Francisco 18
Shanghai 18
Ankara 17
Council Bluffs 17
Norwalk 17
Atlanta 16
Haiphong 16
Mestre 16
Orem 16
Jakarta 15
Vienna 15
Amsterdam 14
Düsseldorf 14
Kent 14
Redwood City 14
Fuzhou 13
Lanzhou 13
Manchester 13
Boydton 12
Campinas 12
Rome 12
Baku 11
Da Nang 11
Dearborn 11
Dongguan 11
Fairfield 11
Tashkent 11
Totale 14.463
Salva come PNG Salva come JPEG
Nome #
Multimodality Imaging in Aldosterone-Induced Cardiomyopathy: Early Detection and Prognostic Implications 366
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 299
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 281
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation 274
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 235
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 232
Abnormal gel flotation caused by contrast media during adrenal vein sampling 231
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 228
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 220
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 209
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 198
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 197
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 194
Novel serum paraoxonase activity assays are associated with coronary artery disease 193
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 192
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test 192
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 191
Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. 188
ApoC-III gene polymorphisms and risk of coronary artery disease 180
Aldosterone to renin ratio in a primary care setting:the Bussolengo study. 179
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 177
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 177
miRNAs purification and analysis from urinary exosomes. 176
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 175
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 172
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 170
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 170
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 169
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 169
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 168
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 168
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 167
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 164
High ferritin and low folate increases PBMCs genomic DNA methylation in association with SHMT1-1420TT variant. 163
Homozygosity for APOCIII variant at position 455 of insulin responsive element promoter region is associated with increased APOC-III levels and risk of coronary artery disease 162
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 162
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 162
Antihypertensive efficacy of spironolactone: what about sex? 161
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 161
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 160
Aldosterone to renin ratio in a primary care setting: the Bussolengo study 159
Vitamins and epigenetics 159
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 158
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 157
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 157
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 157
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 156
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 156
Effects Of Female Sex Hormones And Contraceptive Pill On The Diagnostic Work-Up For Primary Aldosteronism 155
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 155
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 154
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 154
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 154
Determinants of serum ferritin in the metabolic syndrome. 153
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 153
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 152
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 152
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 151
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 150
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 150
Prevalence of body iron excess in the metabolic syndrome. 149
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 149
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 149
Impaired activity of 11--hydroxysteroid dehydrogenase type 2 in glucocorticoid treated and in hypertensive patients from primary and tertiary care. 148
Reduced genomic DNA methylation in peripheral mononuclear cells as an index for the occurrence of cancer disease 148
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 148
Genetic and eviromental determinants of hyperhomocysteinemia in subjects with corocary artery disease 147
Delation variant of ACE gene is associated wwith atherosclerotic renal artery stenosis not with coronary artery disease 147
Delation variant of ACE gene is associated with atherosclerotic renal stenosis not with coronary artery disease 147
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 146
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 146
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 145
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 145
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 145
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 143
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 143
Homocysteine and atheromatous renal artery stenosis 142
Apolipoprotein CIII,metabolic syndrome,and risk of coronary artery disease. 142
Carriership of apolipoprotein CIII –455C gene variant strongly increases the coronary artery disease risk associated with the metabolic sindrome. 142
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. 142
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 142
CYSTATIN C VERSUS CREATININE IN RENOVASCULAR DISEASE. 138
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 138
A late diagnosis of Primary Aldosteronism 138
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 137
Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. 137
Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for? 136
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 136
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease 134
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 134
Primary aldosteronism is a frequent cause of poor blood pressure control despite techically successful endovascular treatment of renal artery stenosis 134
MTHFR C677T genotype-specific thresold values of folate status able to induce mild hyperhomocysteinemia. 134
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 134
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 134
La diagnostica di laboratorio nella sindrome da apparente eccesso di mineralcorticoidi [The laboratory diagnosis of apparent mineralocorticoid excess (AME)] 132
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 131
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. 131
Met-Leu and Gln-Arg PON 1 polymorphisms and mortality after coronary artery by-pass grafing surgery. 130
null 129
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 128
Totale 16.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.963
article - articoli 45.547
book - libri 0
conference - conferenze 27.181
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.235
Totale 147.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021630 0 0 0 0 0 135 31 119 95 24 147 79
2021/20221.168 70 300 15 117 64 41 15 60 54 38 112 282
2022/20232.922 197 315 250 504 295 659 23 206 352 17 66 38
2023/20241.601 62 101 122 137 170 354 46 116 21 57 230 185
2024/20253.452 187 228 130 599 130 121 211 106 506 226 312 696
2025/20267.815 721 561 1.042 1.844 2.958 689 0 0 0 0 0 0
Totale 23.546